Big Pharma, with eye on Anthropic, says AI is shrinking drug discovery timelines
NEW YORK/LONDON, Nov 20 : Artificial intelligence has sped up early-stage drug development work at some of the world's largest pharmaceutical companies this year, cutting by as much as half the time it takes to produce new molecules and move them …